Drug Makers Press For U.S. Trade Sanctions On Thailand
This article was originally published in PharmAsia News
Executive Summary
Drug makers are about to press the U.S. Trade Representative to impose sanctions on Thailand for refusing to drop its compulsory license moves to drive down the price of certain medicines. The director general of Thailand's Intellectual Property Department said the Pharmaceutical Research and Manufacturers of America, which met in Singapore recently, had threatened a strong lobbying effort to get the U.S. policy change. The sanction process envisioned would reduce Thailand from the Priority Watch List where it is now to Priority Foreign Country that makes a nation subject to trade sanctions. (Click here for more